Abstract:Adults living today are most likely to die from a cardiovascular, respiratory, or related disorders (CVRDs). The World Health Organization (WHO) data for 2012indicate that 44 percent of overall deaths and 52 percent of adult deaths globally were due to CVRDs (WHO 2012). The relative contribution of each disorder differs, but in every region except Sub-Saharan Africa, these closely related disorders are the leading causes of death.Most of these disorders are preventable or, if they occur, can be medically treated to improve longevity and reduce disability. Optimal prevention and treatment—which require resources, certainly, but also consistent and persistent therapeutic compliance—remain a challenge even in high-income countries (HICs). Additionally, in low- and middle-income countries (LMICs), the limited capacity to detect these silent diseases and provide early treatment contributes to the rapid emergence of advanced complications and premature death.Cardiovascular, Respiratory, and Related Disorders, volume 5 of the third edition of Disease Control Priorities (DCP3), covers three of the four major noncommunicable diseases (NCDs) prioritized by the United Nations’ (UN) high-level meeting on health in 2011: Cardiovascular diseases (ischemic heart disease and its risk factors, such as obesity, physical inactivity, tobacco use, high blood pressure and abnormal lipids, stroke, peripheral artery disease, structural heart disease, and congestive heart failure) Respiratory diseases Diabetes (United Nations 2011). In addition, we include kidney disease as a related condition; cancers and mental health (also typically grouped among NCDs) are covered in other volumes of DCP3 (box 1.1). These CVRDs are closely related precursors or sequelae for the others, and they share many risk factors and therefore similar prevention and control measures. Box 1.2 summarizes the key messages from DCP3’s volume 5 and provides a framework for systematically addressing CVRDs in LMICs. We present several evidence-based strategies for prevention of CVRDs. We also address the reality that the burden of many arguably preventable disorders is likely to remain high in the coming decades, and that health care systems in LMICs will need to identify viable approaches to treat them. Furthermore, implementing treatment strategies for the aforementioned diseases prevents downstream, highly morbid complications such as heart failure, blindness, or end-stage kidney disease as well as premature mortality among those with preexisting disorders.In this review, we discuss the overarching burden of CVRDs, including reasons why LMICs face disproportionately high premature mortality. We summarize the effectiveness and cost-effectiveness evidence and propose 36 essential interventions (see tables 1.1 and 1.2) that are feasible for LMICs to pursue that can either reduce the incidence of new disease or delay complications among persons who have developed CVRDs. We also present estimates of the cost of this package in typical low- and lower-middle-income country settings and discuss various aspects of package implementation.

Achievement of Guideline-Recommended Targets for Secondary Prevention of Cardiovascular Disease in 38 Low-Income and Middle-Income Countries

Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America.

Achievement of recommended targets for cardiovascular disease prevention in adults with diabetes in 38 low- and middle-income countries

Evaluation of a systematic cardiovascular disease risk reduction strategy in primary healthcare: an exploratory study from Zhejiang, China.

Characteristics of High Risk People with Cardiovascular Disease in Chinese Rural Areas: Clinical Indictors, Disease Patterns and Drug Treatment

Behavioral counseling for cardiovascular disease prevention in 36 low-income and middle-income countries

Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations

Global Inequalities in Access to Cardiovascular Health Care: Our Greatest Challenge.

Cardiovascular, Respiratory, and Related Disorders: Key Messages from Disease Control Priorities, 3rd Edition

Assessing Barriers to Primary Prevention of Cardiovascular Diseases in Low and Middle-Income Countries: A Systematic Review

Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries.

INTERASPIRE a global cross-sectional survey of secondary prevention of cardiovascular disease (CVD) across six WHO regions

Risk factor control and adherence to recommended Lifestyle among US hypertension patients

Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results from the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

Cardiovascular, Respiratory, and Related Disorders: Key Messages and Essential Interventions to Address Their Burden in Low- and Middle-Income Countries

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Disparities in Secondary Prevention between Stroke and Coronary Heart Disease in China: Cross-Sectional Community-Based Study, 2014–2016

Guideline-directed low-density lipoprotein management in high-risk ischemic stroke or transient ischemic attack admissions in China from 2015 to 2019

Heterogeneity among countries in primary cardiovascular prevention guidelines: missed opportunities for adherence and improved outcomes

Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China